In our new monthly round-up, we review the latest clinical research from high-impact medical journals and draw out the findings most relevant to primary and community care nurses. Cahal McQuillan reports.
#ClinicalReport #NHS #GPNs #ClinicalResearch
#Medsky🧪 #neurosky Taking a snippet of #geneticcode that is unique to humans & inserting it into 🐁 helps the animals to grow bigger brains than usual, according to a #Clinicalreport @nature.com
www.nature.com/articles/d41...
www.nature.com/articles/s41...
www.nature.com/immersive/d4...
#Medsky🧪 #Neurosky This #clinicalreport that genetic developmental & #epilepticencephalopathies persist into adulthood with diverse phenotypes. 54.8% of cases had feasible
aetiology-based
treatments, highlighting a need for genome-wide genetic testing in adults.
buff.ly/ZRL8abL
#Medsky🧪 #oncosky #pharmasky In this #clinicalreport mTORC1 regulates pyrimidine salvage by controlling the stability of its rate-limiting enzyme, UCK2. During nutrient depletion or #mTORC1inhibitor treatment . One critical aspect of cell proliferation
Incidence and Prevalence of #NeuroCovid - ME /CFS : A #ClinicalReport
link.springer.com/article/10.1...
PDF Full
link.springer.com/content/pdf/...
#MedSky🧪#IDSky This #clinicalreport case represents a unique example of combined genetic and acquired risk factors for severe #COVID19 & #WestNilevirus infection. The patient harbours the heterozygous (p.Pro554Ser) missense variant in TLR3 gene and is homozygous for the CCR5432 deletion,
MedSky🧪 #Clinicalreport #Metabolomic Novel evidence suggesting that long-term increases in circulating #caffeine may reduce bodyweight and the risk of #osteoarthrosis and #osteoarthritis.
#PublicHealth #Viralimmunology #ClinicalReport Among 🇺🇸 adults at risk for severe #COVID19 the lowest rate of hospitalization was among those receiving 3 or more mRNA vaccine doses & #Paxlovid …
academic.oup.com/cid/advance-...
academic.oup.com/cid/advance-...
pubmed.ncbi.nlm.nih.gov/37806837/
MedSky🧪#IDSky #Clinicalreport @JAMA_current Treatment with #ensitrelvir, an oral SARS-CoV-2 3C-like protease inhibitor developed in 🇯🇵 , shortened #COVID19 symptoms in people who received these #Antiviral within 3 days of symptom onset, researchers reported.
jamanetwork.com/journals/jam...